Item 8.01 Other Events.

On January 18, 2022, Turning Point Therapeutics, Inc. (the "Company") issued a press release announcing business updates, anticipated 2022 clinical and discovery pipeline milestones and its cash, cash equivalents and marketable securities balance as of December 31, 2021. A copy of the press release is filed herewith as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits.

Exhibit
  No.     Description

99.1        Press Release issued by Turning Point Therapeutics, Inc. on January 18,
          2022.

104       Cover Page Interactive Data File (embedded within the Inline XBRL
          document).

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses